Global Intraocular Lens Market Analysis: Industry Revenue by Growing Companies, Alcon, Inc., Johnson & Johnson, Valeant, Carl Zeiss Meditec AG, Rayner, EyeKon Medical, Inc., Lenstec, & Others

Global Intraocular Lens Market was valued at $3,306 million in 2015 and is expected to garner $4,973 million by 2022, registering a CAGR of 5.9% during the forecast period.

Moreover, rise in adoption of premium lens owing to its benefits such as enhanced visual performance and reduced astigmatism supplements the growth of the market. However, unfavorable reimbursement scenario for premium lens and postoperative complications such as refractive errors are expected to impede the market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2092?utm_source=OPR

Intraocular lens (IOLs) are implanted in the eyes to replace the natural lens during cataract surgery. The market has witnessed significant growth in the recent past due to development of new types of IOLs.

Advent of premium IOLs such as multifocal, toric, and accommodating IOLs and rise in incidence of cataract are the key factors that drive the market growth. In addition, rise in geriatric population and proactive initiatives taken by government to eliminate avoidable blindness are anticipated to fuel the demand for IOLs globally. However, postoperative complications such as refractive errors and unfavorable reimbursement scenario for premium intraocular lens restrict the market growth.

The monofocal intraocular lens segment is expected to dominate the market during the analysis period, owing to its advantages such as low and better reimbursement scenario. Silicone generated the maximum revenue, accounting for more than half of the global intraocular lens market in 2015. However, hydrophobic acrylic segment is estimated to exhibit the highest growth rate of 7.1% during the forecast period.

Ambulatory surgery centers generated the highest revenue, accounting for nearly half of the global market, and is estimated to grow at the highest CAGR of 6.7%.

Key Findings of Intraocular Lens Market

• Premium lens segment is expected to grow at a significant CAGR of 8.6%, owing to various benefits such as improved visual performance.
• Ambulatory surgery center segment is projected to grow at a CAGR of 7.1% during the forecast period.
• In terms of volume, the U.S. accounted for more than one-fourth share of the global intraocular lens market.
• France and Germany collectively contributed for more than one-third of the European intraocular lens market in 2015.
• Japan is the major shareholder, accounting for almost one-third of the Asia-Pacific intraocular lens market in 2015.

Asia-Pacific is projected to grow at the highest CAGR of 7.0% during the forecast period owing to improvement in healthcare infrastructures and rise in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs. Technological advancements to develop cost-effective devices offer lucrative opportunities for the market growth.

Buy now and get FREE One Month Knowledge Tree Subscription (valid till 30 Nov'18): https://www.alliedmarketresearch.com/checkout/733216

The major companies profiled in the report include are

• Alcon, Inc. (division of Novartis AG),
• Johnson & Johnson,
• Valeant,
• Carl Zeiss Meditec AG,
• Rayner,
• EyeKon Medical, Inc.,
• Lenstec, Inc.,
• HumanOptics AG,
• STAAR Surgical, and
• HOYA GROUP

The other players operating in the market include PhysIOL s.a., Calhoun Vision Center, and Oculentis GmBH.

Table Of Content

Chapter: 1 INTRODUCTION
1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. RESEARCH METHODOLOGY
1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top winning strategies
3.2.1.1. Competitive intelligence and strategies of companies
3.2.2. Top investment pockets
3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Increase in prevalence of cataract
3.4.1.2. Rise in adoption of premium intraocular lens
3.4.1.3. Increasing government initiatives
3.4.1.4. Increase in pool of geriatric population susceptible to ocular conditions
3.4.1.5. Growth in number of diabetic patients
3.4.2. Restraints
3.4.2.1. Post-operative complications
3.4.2.2. Lack of coverage of premium lens
3.4.3. Opportunities
3.4.3.1. Availability of advanced technologies
3.4.3.2. Emerging nations
3.4.4. Impact analysis
3.5. PORTERS FIVE FORCES ANALYSIS
3.5.1. Bargaining power of buyers
3.5.2. Bargaining power of suppliers
3.5.3. Threat of substitutes
3.5.4. Threat of new entrants
3.5.5. Competitive rivalry
3.6. GOVERNMENT REGULATIONS
3.7. CLINICAL TRIALS

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/intraocular-lens-market.html?utm_source=OPR

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.